Kennedy Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-202,506
| Closed | -$757K | – | 692 |
|
2023
Q3 | $757K | Hold |
202,506
| – | – | 0.02% | 588 |
|
2023
Q2 | $865K | Hold |
202,506
| – | – | 0.02% | 564 |
|
2023
Q1 | $1.39M | Hold |
202,506
| – | – | 0.04% | 448 |
|
2022
Q4 | $1.6M | Sell |
202,506
-30
| -0% | -$238 | 0.05% | 438 |
|
2022
Q3 | $1.95M | Buy |
+202,536
| New | +$1.95M | 0.06% | 419 |
|
2018
Q3 | – | Sell |
-87,248
| Closed | -$1.22M | – | 731 |
|
2018
Q2 | $1.22M | Sell |
87,248
-1,432
| -2% | -$20K | 0.02% | 656 |
|
2018
Q1 | $980K | Sell |
88,680
-8,104
| -8% | -$89.6K | 0.02% | 665 |
|
2017
Q4 | $852K | Sell |
96,784
-1,228
| -1% | -$10.8K | 0.02% | 682 |
|
2017
Q3 | $1.31M | Sell |
98,012
-1,938
| -2% | -$25.9K | 0.02% | 644 |
|
2017
Q2 | $1.43M | Sell |
99,950
-22,944
| -19% | -$329K | 0.03% | 622 |
|
2017
Q1 | $2.6M | Buy |
122,894
+96
| +0.1% | +$2.03K | 0.05% | 556 |
|
2016
Q4 | $3.46M | Buy |
122,798
+67,969
| +124% | +$1.91M | 0.06% | 505 |
|
2016
Q3 | $1.47M | Buy |
+54,829
| New | +$1.47M | 0.03% | 621 |
|